Pieris Pharmaceuticals Inc (PIRS)
11.08
-0.16
(-1.42%)
USD |
NASDAQ |
May 03, 16:00
11.08
0.00 (0.00%)
After-Hours: 20:00
Pieris Pharmaceuticals Market Cap: 13.70M for May 3, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 03, 2024 | 13.70M |
| May 02, 2024 | 13.90M |
| May 01, 2024 | 14.44M |
| April 30, 2024 | 14.48M |
| April 29, 2024 | 14.48M |
| April 26, 2024 | 14.49M |
| April 25, 2024 | 14.35M |
| April 24, 2024 | 14.75M |
| April 23, 2024 | 14.84M |
| April 22, 2024 | 14.45M |
| April 19, 2024 | 14.35M |
| April 18, 2024 | 15.36M |
| April 17, 2024 | 15.54M |
| April 16, 2024 | 16.23M |
| April 15, 2024 | 16.82M |
| April 12, 2024 | 16.99M |
| April 11, 2024 | 17.45M |
| April 10, 2024 | 17.54M |
| April 09, 2024 | 17.99M |
| April 08, 2024 | 17.13M |
| April 05, 2024 | 17.00M |
| April 04, 2024 | 16.97M |
| April 03, 2024 | 17.23M |
| April 02, 2024 | 17.61M |
| April 01, 2024 | 18.50M |
| Date | Value |
|---|---|
| March 28, 2024 | 18.13M |
| March 27, 2024 | 19.16M |
| March 26, 2024 | 18.60M |
| March 25, 2024 | 17.98M |
| March 22, 2024 | 19.79M |
| March 21, 2024 | 19.78M |
| March 20, 2024 | 20.78M |
| March 19, 2024 | 21.32M |
| March 18, 2024 | 20.78M |
| March 15, 2024 | 16.72M |
| March 14, 2024 | 16.92M |
| March 13, 2024 | 17.24M |
| March 12, 2024 | 16.92M |
| March 11, 2024 | 16.82M |
| March 08, 2024 | 17.81M |
| March 07, 2024 | 17.60M |
| March 06, 2024 | 16.73M |
| March 05, 2024 | 17.02M |
| March 04, 2024 | 16.81M |
| March 01, 2024 | 17.12M |
| February 29, 2024 | 16.33M |
| February 28, 2024 | 16.83M |
| February 27, 2024 | 15.89M |
| February 26, 2024 | 16.42M |
| February 23, 2024 | 16.09M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
13.52M
Minimum
Jun 29 2023
390.27M
Maximum
Sep 17 2021
145.81M
Average
147.77M
Median
Sep 02 2020
Market Cap Benchmarks
| NovaBay Pharmaceuticals Inc | 2.856M |
| Palatin Technologies Inc | 34.05M |
| iBio Inc | 6.934M |
| Theriva Biologics Inc | 6.911M |
| Oragenics Inc | 4.794M |
Market Cap Related Metrics
| PS Ratio | 0.2913 |
| Price to Book Value | 0.5121 |
| Price | 11.08 |
| Earnings Yield | -202.2% |